GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MeCure Industries Plc (NSA:MECURE) » Definitions » 3-Year EBITDA Growth Rate

MeCure Industries (NSA:MECURE) 3-Year EBITDA Growth Rate : 0.00% (As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is MeCure Industries 3-Year EBITDA Growth Rate?

MeCure Industries's EBITDA per Share for the six months ended in . 20 was ₦0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Competitive Comparison of MeCure Industries's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, MeCure Industries's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MeCure Industries's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MeCure Industries's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where MeCure Industries's 3-Year EBITDA Growth Rate falls into.


;
;

MeCure Industries 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


MeCure Industries  (NSA:MECURE) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


MeCure Industries 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of MeCure Industries's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


MeCure Industries Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Apapa Oshodi Expressway, Me Cure House, Plot 6, Block H, Oshodi, Lagos, NGA
MeCure Industries Plc is a therapeutics company in the pharmaceutical industry in Lagos, Nigeria. It is principally engaged in the business of manufacturing drugs (tablets, capsules, and syrups) in Nigeria and consists of two categories namely Pharmaceuticals and Nutraceuticals. The Pharmaceuticals segment comprises forty-one (41) drugs such as Ebu 200 & 400 (ibuprofen tablets), Laclox (an anilox formulation), Lamox (an amoxicillin formulation), and Lampicin (an ampicillin formulation), used in treating different ailments. The Nutraceuticals segment consists of 100 products including multivitamins and dietary supplements.

MeCure Industries Headlines

No Headlines